Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- M2 Ingredients
- Study ID
- NCT06870136
- Status
- Recruiting
Conditions
- Cognitive Decline
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Lion's Mane Study Product — DIETARY_SUPPLEMENTThe Lion's Mane Study product contains vegetable cellulose (capsules), Certified organic Lion's Mane (Hericium erinaceus) fruiting body and mycelial biomass cultured on certified whole oats (Avena sativa). Screening assessments, scales and surveys during baseline and during the use of the study product/placebo and end of study experience survey data will be collected.
Study Details
The rationale for this study is to observe differences in cognitive health outcomes such as short term memory and simple reaction time between a consumer-grade and commercially available Lion's mane mushroom product and a placebo control group. Additionally, the study aims to evaluate the impact of the product on cognitive function, mood, focus, motivation, sleep quality, and stress. A consumer-driven, decentralized observational clinical research study is therefore well-suited for evaluating the impact of this product in this population. The study will evaluate cognitive health outcomes in a broad age-range of adults who have chosen to try this product. The study will incorporate memory and cognitive function tests, participant reported outcome questionnaires and surveys. There is no "doctor-patient" relationship as part of this research since the participant as a consumer is making the informed choice to take the product and participate in the observational process with self-reported measures that can be done at home. Findings from this study will contribute knowledge toward the functional mushrooms and cognitive health and the design of future studies.
Key Dates
- Start date
- Feb 21, 2025
- Status verified
- Mar 2025
- Primary completion
- Jul 25, 2025
- Completion
- Sep 17, 2025
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Lion's Mane Study ProductParticipants will be randomized to one of two groups A or B: (1) Lion's Mane Study Product, and (2) Placebo. The Investigators and study team and participants will be blinded to the group assignment.
- Arm: PlaceboParticipants will be randomized to one of two groups A or B: (1) Lion's Mane Study Product, and (2) Placebo. The Investigators and study team and participants will be blinded to the group assignment.
Primary Outcome Measure
Impact on Attention, Short Term & Working Memory [ Time Frame: Participants will complete up to a 14-week study consisting of screening period, randomization and shipping period, a baseline period, and an 8-week product/placebo use period. ]
Central Contacts
- Amy Kazaryan, MPhil8184528996
- Crisel Erfe, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| People Science | Los Angeles | California | 90034 |
Find similar trials in Los Angeles, CA
Related Studies
- Biomarker Exploration in Aging, Cognition and NeurodegenerationPHASE3 · Recruiting · University of California, Irvine · Irvine, California
- Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's DiseaseRecruiting · Neurobehavioral Systems, Inc. · Berkeley, California
- REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage StudyEnrolling By Invitation · Johns Hopkins University · Birmingham, Alabama
- Brain Health Virtual Reality StudyRecruiting · University of California, San Diego · San Diego, California